Eminence Capital, LP Natera, Inc. Transaction History

Eminence Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$47.08 - $55.16 $33.2 Million - $38.9 Million	-705,852 Reduced 62.45%	424,451 $20.7 Million
Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $28.6 Million - $40.1 Million	836,025 Added 284.09%	1,130,303 $45.4 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $490,061 - $752,143	13,270 Added 4.72%	294,278 $12.9 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $3.18 Million - $5.03 Million	112,949 Added 67.21%	281,008 $9.96 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $5.1 Million - $15.3 Million	168,059 New	168,059 $6.84 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Eminence Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Eminence Capital, LP with notifications on news.